英文名稱
4-[6-[(8-Cyclopentyl-6-ethenyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-Piperazinecarboxylic Acid 1,1-Dimethylethyl Ester
4-(6-((8-環戊基-5-甲基-7-氧代-6-乙烯基-7,8-二氫吡啶并[2,3-d]嘧啶-2-基)氨基)吡啶-3-叔丁酯基)哌嗪-1-甲酸叔丁酯
純度
No Data Available
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
Light Yellow to Dark Beige Solid
Dichloromethane (Slightly, Heated), DMSO (Slightly, Heated, Sonicated)
Standards; Pharmaceutical/API Drug Impurities/Metabolites;
4-?[6-?[(8-?Cyclopentyl-?6-?ethenyl-?7,?8-?dihydro-?5-?methyl-?7-?oxopyrido[2,?3-?d]?pyrimidin-?2-?yl)?amino]?-?3-?pyridinyl]?-1-?Piperazinecarboxylic Acid 1,?1-?Dimethylethyl Ester is an impurity of Palbociclib (P139900) an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.